Respiratory Protection: How Attenutin® Drives Demand in Supplements

Seasonal demand for respiratory and immune health support is shaping formulation strategies, with growing interest in clinically validated ingredients that target oxidative stress and inflammatory pathways associated with lung function and respiratory resilience.

Attenutin™ is a specially formulated natural bioflavonoid composition designed to support the protective lining of the respiratory track and maintain healthy lung function. With a long history of safe human consumption, it offers a clinically evaluated botanical approach for respiratory and immune support during periods of increased physiological stress.

Recent research highlights the role of Attenutin™ in supporting respiratory protection under oxidative stress conditions, including modulation of key inflammatory markers such as TNF-α, IL-1β and IL-6.

Findings also indicate a reduction in extracellular HMGB1, a key mediator of lung inflammation, suggesting a role in maintaining healthy respiratory function during environmental stress exposure¹.

A further study demonstrated broader immune benefits. In a clinical trial, Attenutin™ (500mg daily) was evaluated prior to and following influenza vaccination. Results showed a significant increase in IgA and IgG antibody levels, indicating enhanced humoral immune response, alongside improved antioxidant status as measured by glutathione peroxidase activity².

Attenutin™ is developed by Unigen, a U.S. based company specialising in scientifically validated botanical blends, including AmLexin™, Anivestin™, and Univestin®. Using its proprietary Phytologix® Technology Platform, each ingredient is standardised to ensure consistency, quality and clinical relevance for targeted health applications.

For more information, download our Attenutin™ product profile sheet here or contact us.

_{References
(1) Yimam M, et al (2023). A Standardized Botanical Composition Mitigated Acute Inflammatory Lung Injury and Reduced Mortality through Extracellular HMGB1 Reduction. doi.org/10.3390/molecules28186560.
(2) Erin D. Lewis, et al (2022)  Role of Acacia catechu and Scutellaria baicalensis in Enhancing Immune Function Following Influenza Vaccination of Healthy Adults: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. doi.org/10.1080/27697061.2022.2145525.}